Muckenhuber, A., Berger, A. K., Eils, R., Stenzinger, A., Jäger, D., & Springfeld, C. (2018). Pancreatic ductal adenocarcinoma subtyping using the biomarkers hepatocyte nuclear factor-1A and cytokeratin-81 correlates with outcome and treatment response. Clinical cancer research, 24(2), . https://doi.org/10.1158/1078-0432.CCR-17-2180
Chicago-Zitierstil (17. Ausg.)Muckenhuber, Alexander, Anne Katrin Berger, Roland Eils, Albrecht Stenzinger, Dirk Jäger, und Christoph Springfeld. "Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response." Clinical Cancer Research 24, no. 2 (2018). https://doi.org/10.1158/1078-0432.CCR-17-2180.
MLA-Zitierstil (9. Ausg.)Muckenhuber, Alexander, et al. "Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response." Clinical Cancer Research, vol. 24, no. 2, 2018, https://doi.org/10.1158/1078-0432.CCR-17-2180.